This announcement is a separate document:
仟源医药：上海荣正企业咨询服务（集团）股份有限公司关于山西仟源医药集团股份有限公司2024年限制性股票激励计划（草案）之独立财务顾问报告
Shanxi C&Y Pharmaceutical Group: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft) of Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.